- Home
- / CHA Vaccine Institute
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CHA Vaccine Institute financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₩370.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 500.0M | 179.5M | 294.1M | 370.7M |
| Cost of goods sold | 157.0M | 19.0M | 34.5M | 23.9M |
| Gross profit | 435.6M | 250.3M | 2.6B | 355.1M |
| Gross profit margin, % | 87.1% | 139.5% | 878.9% | 95.8% |
| Operating expense total | 6.2B | 6.2B | 6.1B | 7.6B |
| Depreciation and amortization | 245.5M | 417.4M | 533.3M | 491.2M |
| EBITDA | (5.7B) | (6.0B) | (3.6B) | (7.2B) |
| EBITDA margin, % | -1149.3% | -3321.8% | -1210.6% | -1941.6% |
| EBIT | (6.0B) | (6.4B) | (4.1B) | (8.5B) |
| EBIT margin, % | -1198.4% | -3554.3% | -1391.9% | -2292.0% |
| Interest income | 179.9M | 1.0B | 2.3B | 1.4B |
| Interest expense | 2.1B | 2.6B | 2.6B | 1.3B |
| Pre tax profit | (18.4B) | (6.7B) | (2.1B) | (10.4B) |
| Income tax expense | (353.8M) | (275.5M) | ||
| Net Income | (18.4B) | (6.7B) | (1.7B) | (10.1B) |